Genesco Inc.
GCO
$21.00
-$0.22-1.04%
Weiss Ratings | GCO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | GCO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Fair | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | GCO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.84 | |||
Price History | GCO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -35.60% | |||
30-Day Total Return | -51.08% | |||
60-Day Total Return | -51.38% | |||
90-Day Total Return | -18.03% | |||
Year to Date Total Return | -49.78% | |||
1-Year Total Return | -14.46% | |||
2-Year Total Return | -42.45% | |||
3-Year Total Return | -67.95% | |||
5-Year Total Return | 28.21% | |||
52-Week High % Change | -53.12% | |||
52-Week Low % Change | 4.53% | |||
Price | GCO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $44.80 | |||
52-Week Low Price | $20.09 | |||
52-Week Low Price (Date) | Mar 12, 2025 | |||
52-Week High Price (Date) | Dec 18, 2024 | |||
Valuation | GCO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 235.46M | |||
Enterprise Value | 686.54M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -2.45 | |||
Earnings Per Share Growth | 255.16% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.10 | |||
Price/Book (Q) | 0.46 | |||
Enterprise Value/Revenue (TTM) | 0.30 | |||
Price | $21.00 | |||
Enterprise Value/EBITDA (TTM) | 11.60 | |||
Enterprise Value/EBIT | 92.68 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | GCO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 10.74M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | GCO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 615 367 7000 | |||
Address | 535 Marriott Drive Nashville, TN 37214 | |||
Website | genesco.com | |||
Country | United States | |||
Year Founded | 1934 | |||
Profitability | GCO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 0.31% | |||
Profit Margin | -1.12% | |||
Management Effectiveness | GCO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 0.32% | |||
Return on Equity | -- | |||
Income Statement | GCO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 2.32B | |||
Total Revenue (TTM) | 2.32B | |||
Revenue Per Share | $215.89 | |||
Gross Profit (TTM) | 1.09B | |||
EBITDA (TTM) | 59.20M | |||
EBIT (TTM) | 7.41M | |||
Net Income (TTM) | -26.08M | |||
Net Income Avl. to Common (TTM) | -26.08M | |||
Total Revenue Growth (Q YOY) | 2.94% | |||
Earnings Growth (Q YOY) | -386.05% | |||
EPS Diluted (TTM) | -2.45 | |||
EPS Diluted Growth (Q YOY) | -396.91% | |||
Balance Sheet | GCO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 33.58M | |||
Cash Per Share (Q) | $3.13 | |||
Total Current Assets (Q) | 659.70M | |||
Total Preferred Equity (Q) | 0.82 | |||
Total Equity (Q) | 516.90M | |||
Current Ratio (Q) | 1.563 | |||
Book Value Per Share (Q) | $46.03 | |||
Total Assets (Q) | 1.44B | |||
Total Current Liabilities (Q) | 422.08M | |||
Total Debt (Q) | 572.18M | |||
Total Liabilities (Q) | 918.62M | |||
Total Common Equity (Q) | 516.08M | |||
Cash Flow | GCO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -27.40M | |||
Cash from Financing (TTM) | 54.54M | |||
Net Change in Cash (TTM) | -1.58M | |||
Levered Free Cash Flow (TTM) | -51.73M | |||
Cash from Operations (TTM) | -29.11M | |||